Skip to content

Perioperatief behoud van de globale weefselperfusie en volemische status tijdens abdominale chirurgie: Nexfin hartminuutvolume en pulse pressure variatie versus arteriële bloeddruk-gestuurde therapie.

Perioperative maintenance of global tissue perfusion and volemic state in abdominal surgery: Nexfin cardiac output and pulse pressure variation versus arterial blood pressure-guided therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26570
Enrollment
250
Registered
2012-01-19
Start date
2012-01-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing abdominal surgery

Interventions

Hemodynamic guidance based on arterial blood pressure or cardiac output with pulse pressure variation. 1. Mean Arterial Pressure (MAP), measured with a non-invasive continuous arterial sphygmomanomet
2. Pulse Pressure Variance (PPV), also measured with a non-invasive continuous arterial sphygmomanometer.

Sponsors

VU University Medical Center Westfries Gasthuis Hoorn
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective abdominal surgery; 2. Age 18-85 years; 3. Duration of surgery > 90 minutes; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Preexisting cardiac arrhythmias; 2. Emergency operation; 3. ICU patients; 4. Body mass index below 20 kg/m2 and above 40 kg/m2; 5. Patients without an invasive arterial line; 6. Decompensatio cordis; 7. Aortic valve disease; 8. Ejection fraction 30 mm Hg, TAPSE < 18 mm; 11. Incapacitated patients.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is defined as postoperative morbidity based on the incidence of a number of predefined complications until 7 days after surgery. These parameters include, among others, reoperation, infections, rehabilitation and restoration of gastrointestinal function.

Secondary

MeasureTime frame
Secondary endpoints include hospital length of stay and microcirculatory perfusion.

Contacts

Public ContactChrista Boer

VU University Medical Center, Department of Anesthesiology

c.boer@vumc.nl+31 (0)20 4443830

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)